Extent of Blood sugar variability 1 year after diagnosis of diabetes predicts CV events

Written By :  Dr. Kamal Kant Kohli
Published On 2022-06-05 14:30 GMT   |   Update On 2022-06-05 14:30 GMT

The study from Surrey suggests that controlling blood sugar levels within the first year of diagnosis reduces the incidence of major cardiovascular events. Furthermore, the team also found that the more a patient's blood levels varied 12-months after diagnosis, the more likely they were to experience dangerous cardiovascular events.

Dr Martin Whyte, co-author of the study and Reader in Metabolic Medicine at the University of Surrey, said:

Advertisement

"The conventional wisdom has been to slowly and steadily treat type 2 diabetes with diet and medicine dose-escalation over years-the period over which it took people to reduce their sugar levels after diagnosis was thought less important for major vascular protection. However, our observational study suggests that getting blood levels under control quickly-within the first 12 months after diagnosis-will significantly help reduce cardiovascular events."

Type 2 diabetes is a common condition that results in the level of sugar in the blood becoming too high. The condition is linked to obesity or a family history of type 2 diabetes and can increase a person's risk of getting serious health conditions.

The University of Surrey's study used Royal College of General Practitioners' Research and Surveillance Centre database to perform a comprehensive examination of glycaemic control achieved within the first year of diagnosis and subsequent blood sugar level variability with cardiovascular disease incidents. 

For more details, visit on the following link:

http://dx.doi.org/10.1111/dom.14705

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News